FDA label b61a4284-b8de-481f-b090-ffb8b05f8a7a

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

SPL set ID
ac076444-77d8-48a0-8115-bbd26db3e98d
SPL ID
b61a4284-b8de-481f-b090-ffb8b05f8a7a
Version
1
Effective date
2018-03-28
Source export date
2026-11-13
Source partition
1
Source file
https://download.open.fda.gov/drug/label/drug-label-0001-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-11-13/4245fd4310917b72c4a58c789d30a0b365e492ef46f48e107e3c3e16139b0499/drug-label-0001-of-0014.json.zip
Source manifest SHA-256
8f2b6d063d44586cf97cedcdf1bdf9e261cc88632cc6855424b801bb206208d7
Import run
20261116T150851Z
Imported at
2026-11-16 15:25:20

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

ADVERSE REACTIONS The majority of reported adverse effects associated with CTC-310 result from Crotoxin’s neurotoxic effects. In clinical studies with CTC-310, subjects reported the following dose related adverse effects; anxiety, increased blood pressure, diplopia, nystagmus and strabismus.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.